Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

E-Star BioTech

Clinical Phase 2

Keywords: cardiovascular metabolic renal Difficult to Control Hypertension Resistant Hypertension

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

Nov 17, 2024 Trial start Phase 2: To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension source ↗
Dec 20, 2021 Trial start Phase 1: Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects source ↗

Upcoming milestones

Jul 1, 2027 (ESTIMATED) · Phase 2 · To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension · NCT06343298

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

Record	Title	Phase	Status	Start	Primary completion
NCT06343298	To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension	Phase 2	Recruiting	Nov 17, 2024	Jul 1, 2027 (estimated)
NCT05247528	Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects	Phase 1	Completed	Dec 20, 2021	Oct 31, 2022 (actual)